Introduction

Kawasaki disease is an acute, self-limited medium-vessel vasculitis that occurs primarily in young children. Although many children recover without complication, untreated or undertreated disease carries substantial risk of coronary artery abnormalities, including dilation and aneurysm formation. Because there is no single pathognomonic laboratory test, diagnosis rests heavily on recognizing a characteristic pattern of prolonged fever together with a constellation of mucocutaneous signs and, in some cases, cervical lymphadenopathy.

The classic (complete) case definition familiar to clinicians requires fever of sufficient duration plus a minimum number of principal clinical features, after thoughtful consideration of alternative diagnoses. In practice, many children have incomplete (atypical) Kawasaki disease, with fewer classic findings but still at risk for cardiac involvement—particularly infants, in whom the clinical picture may be subtle.

Why diagnostic criteria matter

Timely recognition matters because therapy—most commonly intravenous immunoglobulin (IVIG) in conjunction with anti-inflammatory management per protocol—aims to reduce the incidence and severity of coronary artery lesions. Delays may occur when fever and rash are attributed solely to viral illness, when cervical adenopathy suggests bacterial lymphadenitis, or when conjunctival injection is mistaken for uncomplicated adenoviral conjunctivitis.

Diagnostic criteria therefore serve two roles: they help standardize teaching and communication, and they prompt clinicians to ask whether the overall illness trajectory, age, examination findings, and supportive data fit a high-risk vasculitic process rather than a self-limited exanthem.

Classic (complete) clinical criteria

The widely taught complete clinical case definition can be summarized as follows:

• Fever persisting for at least five days, or fever until the time of IVIG administration when treatment is given before the fifth day of fever (wording used in many guideline summaries).
• Plus four or five of the following principal clinical features, not better explained by another more likely condition.

When these elements align, clinicians typically pursue inflammatory markers, baseline cardiac evaluation per local protocol, and discussion of therapy with pediatrics and/or pediatric cardiology. Exact management should follow current institutional pathways and specialist consultation rather than any online checklist alone.

The five principal clinical features

Each principal feature is a clinical pattern rather than a single isolated sign. Experienced clinicians integrate evolution over days, associated symptoms, and epidemiologic context.

1. Bilateral conjunctival injection

Kawasaki-associated conjunctival involvement is typically bulbar, bilateral, and described as non-exudative injection. Copious purulent discharge more strongly suggests bacterial conjunctivitis; watery discharge with significant lid edema and petechiae may raise consideration of adenoviral infection. The Kawasaki pattern is often described as “limbal sparing” in teaching, though clinical overlap exists, so the feature should be interpreted as part of the whole illness rather than in isolation.

2. Mucous membrane changes of the oropharynx and lips

Oral findings may include erythematous cracked lips, a strawberry tongue (prominent papillae with erythema), and diffuse oral mucosal erythema or pharyngeal injection. These changes can be mistaken for streptococcal pharyngitis or viral stomatitis. Supportive context includes the presence of other principal features, the fever pattern, and laboratory clues, but clinical judgment remains central.

3. Polymorphous rash

The exanthem is often described as polymorphous, meaning it may appear morbilliform, macular, urticarial, targetoid, or scarlatiniform in different patients. It frequently involves the trunk and extremities and may be accentuated in the groin with subsequent desquamation in some cases. Drug eruption remains an important mimic; a careful medication history and evolution of findings are essential.

4. Peripheral extremity changes

Acute-phase findings may include erythema or edema of the hands or feet, sometimes with pain or refusal to bear weight. Later in convalescence, periungual peeling may appear; this temporal pattern can be supportive when the history is available, though it is not required for initial suspicion. Cellulitis, reactive arthritis, and other causes of extremity erythema should be considered when distribution or systemic features are atypical.

5. Cervical lymphadenopathy

Cervical lymph node enlargement in Kawasaki disease is often unilateral and may involve a node measuring roughly 1.5 cm or more in diameter. It is the least common of the principal features, so its absence does not exclude disease when other features and risk factors are present. Bacterial cervical adenitis, atypical mycobacterial infection, and suppurative complications can mimic or coexist; evaluation may require imaging or surgical consultation depending on severity and clinical suspicion.

Principal features at a glance

Feature	Typical pattern	Common mimics (examples)
Conjunctival injection	Bilateral, bulbar, non-exudative	Adenovirus, bacterial conjunctivitis, allergic eye disease
Oral mucosal changes	Cracked lips, strawberry tongue, mucosal erythema	Strep pharyngitis, viral stomatitis, drug-related mucositis
Rash	Polymorphous, often truncal	Viral exanthems, scarlet fever, drug eruption
Extremity changes	Hand/foot erythema or edema; later periungual peeling	Cellulitis, reactive arthritis, staphylococcal scalded skin spectrum (context-dependent)
Cervical lymphadenopathy	Often unilateral; node ≥ ~1.5 cm	Bacterial adenitis, other infectious and non-infectious lymphadenopathy

Incomplete (atypical) Kawasaki disease

Many children with coronary risk do not present with four or five principal features. Incomplete Kawasaki disease refers to prolonged fever and clinical/laboratory/echocardiographic features that raise concern despite fewer classic signs. This is especially true in young infants, who may appear irritable or minimally symptomatic aside from fever, and in whom classic mucocutaneous findings may never fully declare themselves.

Published algorithms for suspected incomplete disease typically incorporate elements such as C-reactive protein and erythrocyte sedimentation rate, complete blood count (including platelet count trajectory), albumin, hepatic transaminases, urinalysis, and echocardiography. The purpose is not to replace clinician judgment but to structure risk assessment when the classic bedside checklist is not satisfied.

Multisystem inflammatory conditions that emerged in recent years—including entities temporally related to viral pandemics—may share fever, inflammation, and cardiovascular involvement with Kawasaki disease yet differ in epidemiology, shock phenotype, age distribution, and ancillary testing. When features overlap, specialist guidance and institutional pathways are particularly important.

Fever duration and treatment timing

The classic teaching threshold of five days of fever reflects the typical time course for the full mucocutaneous picture to emerge. In real practice, clinicians sometimes treat earlier when suspicion is high and other data support the diagnosis, recognizing that IVIG may alter the natural history of fever duration. Criteria summaries therefore sometimes phrase fever as extending through the initiation of therapy rather than strictly requiring five full days before evaluation.

From a documentation standpoint, recording daily fever pattern, antipyretic response, and evolution of examination findings improves interpretability for consultants and for longitudinal care.

Coronary artery involvement

Kawasaki disease is feared primarily for its association with coronary artery aneurysms and other vascular changes. Echocardiography is a cornerstone of initial assessment and follow-up in suspected or confirmed disease, with protocols varying by institution and disease severity. Even when classic criteria are not met, echocardiographic findings may contribute to risk stratification in selected scenarios as guided by pediatric cardiology.

Clinicians should avoid anchoring solely on “rule-in” checklists when a child has prolonged unexplained fever, persistent inflammation, or evolving cardiac concerns, particularly in high-risk age groups.

Using the CalcMD checklist responsibly

The companion calculator on CalcMD encodes the principal-feature checklist and a fever duration gate aligned with classic teaching. It can help learners and clinicians organize bedside findings and communicate whether a presentation meets the complete clinical pattern.

It does not compute incomplete Kawasaki algorithms, laboratory cutoffs, or echocardiographic results. It does not determine therapy, dosing, or follow-up intervals. Any output should be interpreted in the context of age, illness trajectory, institutional protocols, and specialist input.

Clinical documentation tips

• Describe each principal feature explicitly (laterality, distribution, presence or absence of exudate, measured node size when applicable).
• Note competing diagnoses considered and key findings that argue for or against them.
• Record inflammatory markers, platelet count, and cardiac imaging plans or results when obtained.
• When criteria are not met but suspicion remains, document the rationale for observation, repeat examination, expanded testing, or consultation.